Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
作者信息
Simms Robert W, Lafyatis Robert
出版信息
Rheumatology (Oxford). 2010 Feb;49(2):201-2. doi: 10.1093/rheumatology/kep421. Epub 2009 Dec 23.
PMID:20032221
Abstract
摘要
相似文献
1
Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
Rheumatology (Oxford). 2010 Feb;49(2):201-2. doi: 10.1093/rheumatology/kep421. Epub 2009 Dec 23.
2
Is there a role for B-cell depletion as therapy for scleroderma? A case report and review of the literature.
Semin Arthritis Rheum. 2010 Oct;40(2):127-36. doi: 10.1016/j.semarthrit.2009.09.003. Epub 2009 Dec 11.
3
Treating human autoimmune disease by depleting B cells.
Ann Rheum Dis. 2002 Oct;61(10):863-6. doi: 10.1136/ard.61.10.863.
4
Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study.
Rheumatology (Oxford). 2010 Apr;49(4):691-6. doi: 10.1093/rheumatology/kep446. Epub 2010 Jan 4.
5
Specific Antinuclear Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis Are Associated with Improvement of Skin Thickening.
J Rheumatol. 2016 Jan;43(1):247-9. doi: 10.3899/jrheum.150105.
6
B cell depletion therapy in rheumatic disease.
Best Pract Res Clin Rheumatol. 2006 Oct;20(5):915-28. doi: 10.1016/j.berh.2006.05.010.
7
Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.
Lupus. 2013 Apr;22(5):538-40. doi: 10.1177/0961203313477899. Epub 2013 Feb 19.
8
Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
J Rheumatol. 2011 Apr;38(4):587-9. doi: 10.3899/jrheum.101350.
9
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
Autoimmun Rev. 2010 Sep;9(11):716-20. doi: 10.1016/j.autrev.2010.07.013. Epub 2010 Jul 25.
10
Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
Lupus. 2010 Sep;19(10):1256-7. doi: 10.1177/0961203310373107. Epub 2010 Jun 9.
引用本文的文献
1
Egr-ly awaiting a "personalized medicine" approach to treat scleroderma.
J Cell Commun Signal. 2012 Jun;6(2):111-3. doi: 10.1007/s12079-012-0160-8. Epub 2012 Feb 15.
2
Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: comment on the article by Yoo.
Rheumatol Int. 2011 Jun;31(6):841-2. doi: 10.1007/s00296-010-1485-3. Epub 2010 Apr 8.
Zotero 插件